Status of the Endothelium-derived Hyperpolarizing Factor Pathway in Coronary Arteries After Heterotopic Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 48-55

  Perrault, Louis P ^a   Aubin, Marie Claude ^a,b   Malo, Olivier ^b   Thollon, Catherine ^c   Villeneuve, Nicole ^c   Vilaine, Jean Paul ^c   Vanhoutte, Paul M ^d  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CROMAKALIM; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) NITROARGININE; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN F2 ALPHA; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HOMEOSTASIS; HYPERPOLARIZATION; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

ACTION POTENTIALS; ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; MALE; SEVERITY OF ILLNESS INDEX; SWINE; TRANSPLANTATION, HETEROTOPIC; VASODILATION;

EID: 33846213630     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.015     Document Type: Article

References (32)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 24 (2005) 945-955
2. Billingham M.E. Cardiac transplantation atherosclerosis. Transplant Proc 19 (1987) 19-25
3. Davis S.F., Yeung A.C., Meredith I.T., et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post-transplant. Circulation 93 (1996) 457-462
4. Madsen J.C., Sachs D.H., Fallon J.T., and Weissman N.J. Cardiac allograft vasculopathy in partially inbred miniature swine. Time course, pathology, and dependence on immune mechanisms. J Thorac Cardiovasc Surg 111 (1996) 1230-1239
5. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
6. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report-1999. J Heart Lung Transplant 18 (1999) 611-616
7. Drinkwater D.C., Rudis E., Laks H., et al. University of Wisconsin solution versus Standford cardioplegic solution and the development of cardiac allograft vasculopathy. J Heart Lung Transplant 14 (1995) 891-896
8. Knight R.J., Dikman S., Liu H., and Martinelli G.P. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 64 (1997) 1102-1107
9. Perrault L.P., Nickner C., Desjardins N., Dumont E., Thai P., and Carrier M. Improved preservation of coronary endothelial function with Celsior compared with blood and crystalloid solutions in heart transplantation. J Heart Lung Transplant 20 (2001) 549-558
10. Kupatt C., Habazettl H., Goedecke A., et al. Tumor necrosis factor-α contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ Res 84 (1999) 392-400
11. Weis M., Wildhirt S.M., Schulze C., et al. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 36 (2000) 776-784
12. Nakashima M., Mombouli J.V., Taylor A.A., and Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human arteries. J Clin Invest 92 (1993) 2867-2871
13. Campbell W.B., Gebremedhin D., Pratt P.F., and Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78 (1996) 415-423
14. Kilpatrick E.V., and Cocks T.M. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol 112 (1994) 557-565
15. 2 contribute to ACh-induced hyperpolarization of pressurized canine coronary microvessels. Am J Physiol Heart Circ Physiol 285 (2003) H1939-H1948
16. Cohen R.A., and Vanhoutte P.M. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 92 (1995) 3337-3349
17. Félétou M., and Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 93 (1988) 515-524
18. Corriu C., Félétou M., Canet E., and Vanhoutte P.M. Inhibitors of the cytochrome P450 mono-oxygenase and endothelium-dependent hyperpolarization in the guinea-pig isolated carotid artery. Br J Pharmacol 117 (1996) 607-610
19. Najibi S., Cowan C.L., Palacino J.J., and Cohen R.A. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol 266 (1994) H2061-H2067
20. Perrault L.P., Bidouard J.P., Janiak P., et al. Time course and mechanisms of coronary endothelial dysfunction during acute untreated rejection after heart transplantation. J Heart Lung Transplant 16 (1997) 643-657
21. He G.W., Yang C.Q., and Yang J.A. Depolarizing cardiac arrest and endothelium-derived hyperoplarizing factor mediated hyperpolarization and relaxation in coronary arteries: the effect and mechanism. J Thorac Cardiovacs Surg 113 (1997) 932-941
22. Aubin M.C., Carrier M., Shi Y.F., Tardif J.C., and Perrault L.P. Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. J Cardiovasc Pharmacol 47 (2006) 702-710
23. Olmos L., Mombouli J.V., Illiano S., and Vanhoutte P.M. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol 268 (1995) H865-H870
24. Perrault L.P., Bidouard J.P., Janiak P., et al. Impairment of G-protein-mediated signal transduction in the porcine coronary endothelium during rejection after heart transplantation. Cardiovasc Res 43 (1999) 457-470
25. Perrault L.P., Bidouard J.P., Jacquemin C., et al. Cyclic GMP is decreased after heterotopic heart transplantation. FASEB J II (1997) A246
26. Chu W., Wu Y.C., Chou Y.C., et al. Endothelium-dependent relaxation of canine pulmonary artery after prolonged lung graft preservation in University of Wisconsin: role of L-arginine supplementation. J Heart Lung Transplant 23 (2004) 592-598
27. Nagao T., Iiiano S., and Vanhoutte P.M. Heterogenous distribution of endothelium-dependent relaxations resistant to nitro-L-arginine in the arterial tree of the rat. Am J Physiol 263 (1992) 90-94
28. Pearson P.J., Schaff H.V., and Vanhoutte P.M. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res 67 (1990) 385-393
29. Thollon C., Bidouard J.P., Cambarrat C., Delescluse I., Vanhoutte P.M., and Vilaine J.P. Endothelium-dependent hyperpolarization in porcine coronary arteries with regenerated endothelium: decreased response to serotonin and increased hyperpolarization to bradykinin. J Vasc Res 37 (1997) 40
30. Bény J.L., Zhu P., and Haefliger I.O. Lack of bradykinin-induced smooth muscle hyperpolarization despite heterocellular dye coupling and endothelial cell hyperpolarization in porcine ciliary artery. J Vasc Res 35 (1997) 344-350
31. Kauser K., and Rubanyi G.M. Bradykinin-induced, nitro-L-arginine-insentitive endothelium-dependent relaxation of porcine coronary artery is not mediated by bioassayable substances. J Cardiovasc Pharmacol 20 suppl (1992) S101-S104
32. Sudhir K., MacGregor J.S., DeMarco T., et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 90 (1994) 3018-3023